Ortho Regenerative Technologies announce enrollment of first patient in its U.S phase I/II rotator cuff tear repair clinical trial
First patient surgery completed; additional surgeries already scheduled8 clinical centres now fully initiated and recruiting / screening for patients MONTREAL, July 27, 2022 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) ("Ortho" or the...